The effect of long-term antipsychotic treatment on prolactin
- PMID: 16768639
- DOI: 10.1089/cap.2006.16.317
The effect of long-term antipsychotic treatment on prolactin
Abstract
Objective: This naturalistic, cross-sectional study was designed to assess the risk of prolactin level elevation and associated side effects in youths taking long-term atypical antipsychotic medication.
Method: Subjects were enrolled from outpatient child psychiatric treatment settings in upstate New York who were taking risperidone, olanzapine, or quetiapine for at least 6 months. Demographic data, medication history, and side effects were elicited at the initial interview. Two fasting morning serum prolactin levels were obtained 1 month apart, and the results were averaged.
Results: Fifty outpatient youths, with a median age of 13 years, were enrolled in the study. The median overall duration of use of an atypical antipsychotic was 22.1 months. The median dose of medication for risperidone was 1.5 mg/day, for olanzapine 10 mg/day, and for quetiapine 200 mg/day. The mean prolactin level among all patients on risperidone was significantly greater than controls, as well as for those on quetiapine or olanzapine.
Conclusions: The risk of hyperprolactinemia with long-term use of risperidone appears to be significantly greater than for olanzapine or quetiapine. Overt side effects were infrequent in the overall sample, but serum prolactin assessment is recommended for youths taking risperidone chronically. Because of variability found in sequential prolactin samples, repeat samples may be warranted.
Similar articles
-
Elevated prolactin levels in male youths treated with risperidone and quetiapine.J Child Adolesc Psychopharmacol. 2005 Dec;15(6):893-900. doi: 10.1089/cap.2005.15.893. J Child Adolesc Psychopharmacol. 2005. PMID: 16379509
-
Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.J Am Acad Child Adolesc Psychiatry. 2014 Nov;53(11):1179-90,1190.e1-4. doi: 10.1016/j.jaac.2014.08.009. Epub 2014 Sep 2. J Am Acad Child Adolesc Psychiatry. 2014. PMID: 25440308
-
Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.Neuro Endocrinol Lett. 2007 Dec;28(6):881-8. Neuro Endocrinol Lett. 2007. PMID: 18063941 Clinical Trial.
-
A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents.J Child Adolesc Psychopharmacol. 2004 Fall;14(3):350-8. doi: 10.1089/cap.2004.14.350. J Child Adolesc Psychopharmacol. 2004. PMID: 15650492 Review.
-
Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.J Child Adolesc Psychopharmacol. 2009 Aug;19(4):403-14. doi: 10.1089/cap.2008.0120. J Child Adolesc Psychopharmacol. 2009. PMID: 19702492 Review.
Cited by
-
Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.CNS Drugs. 2009 Dec;23(12):1003-21. doi: 10.2165/11530020-000000000-00000. CNS Drugs. 2009. PMID: 19958039 Review.
-
Risperidone Induced Hyperprolactinemia: From Basic to Clinical Studies.Front Psychiatry. 2022 May 6;13:874705. doi: 10.3389/fpsyt.2022.874705. eCollection 2022. Front Psychiatry. 2022. PMID: 35599770 Free PMC article. Review.
-
Prolactin serum concentrations during aripiprazole treatment in youth.J Child Adolesc Psychopharmacol. 2013 May;23(4):282-9. doi: 10.1089/cap.2012.0062. Epub 2013 May 6. J Child Adolesc Psychopharmacol. 2013. PMID: 23647135 Free PMC article. Review.
-
The short-term effects of risperidone-induced hyperprolactinemia on lipid metabolism in drug-naïve children and adolescents.Psychiatry Investig. 2015 Jan;12(1):55-60. doi: 10.4306/pi.2015.12.1.55. Epub 2015 Jan 12. Psychiatry Investig. 2015. PMID: 25670946 Free PMC article.
-
Atypical antipsychotic medication in preschool children.Curr Psychiatry Rep. 2007 Jun;9(3):181-3. doi: 10.1007/s11920-007-0016-8. Curr Psychiatry Rep. 2007. PMID: 17521512 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical